Catherine Moukheibir Insider Trades & Stock Holdings
Catherine Moukheibir at MoonLake Immunotherapeutics has 3 Form 4 trades on file since Jun 16, 2026 across 2 companies. Latest filing: acquired 22.20K shares of $MLTX on Jun 17, 2026.
- Trades on file
- 3
- Open-market bought
- $0
- Open-market sold
- $0
- Net open-market
- $0
- Latest filing
- Jun 17, 2026
All insider trades by Catherine Moukheibir
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $MLTX | Buy (Grant or award) | 22.20K | $0 | — | +4.2% | +2.6% | Read | ||||||
| $IRWD | Buy (Grant or award) | 63.48K | $0 | — | +5.5% | +5.7% | — | ||||||
| $IRWD | Buy (Grant or award) | 63.48K | $0 | — | +5.5% | +5.7% | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Catherine Moukheibir traded
Frequently asked questions
What was Catherine Moukheibir's latest insider trade?
acquired 22.20K shares of $MLTX on Jun 17, 2026.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.